Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Mykndrsnon Jul 08, 2021 10:35am
157 Views
Post# 33511719

RE:RE:Aristotle has finally launched...

RE:RE:Aristotle has finally launched...Response from AVRT inquiry. Everything in holding pattern for the moment.

Your submission form for the AVRT program has been received.

WELCOME to Stage Zero Life Sciences’ comprehensive telehealth program that uses advanced diagnostics and evidence based clinical protocols to keep individuals informed and to reduce the risk of developing cancer and other chronic diseases.

This is the first step in your continued journey of optimum health!

Included in this platform:

-Aristotle: the first multi-cancer test panel using a single sample of blood. This cutting-edge technology detects the molecular signatures of 9 specific cancers in women and 6 cancers in men.

-ColonSentry: A proprietary liquid biopsy test that uses advanced gene expression (mRNA) technology for the early identification of Colorectal Cancer.

-Prostate Health Index (PHI): An FDA approved blood test that can differentiate prostate cancer from benign conditions in men with elevated PSA, enabling a more informed decision if a prostate biopsy is indicated.

We are in the process of finalizing all aspects of the program. A case manager will reach out to you soon to review the protocols and get you started on living your best life.

Best in health,
<< Previous
Bullboard Posts
Next >>